Free Motion for Miscellaneous Relief - District Court of Delaware - Delaware

Case 1:08-cv-00066-JJF Document 10 Filed O3/13/2008 Page 1 of 2
IIN TI~IE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
I
THE PROCTER & GAMBLIE COMPANY. )
I
Plaintifil )
I
vt ) Civil Action No. 08—66—.lJF
I
TEVA PIIARMACEUTICALS USA, INC, )
I
Defendant. )

REQUEST FOR ENTRY OF PROPOSED ORDER OF FINAL JUDGMENT
Pursuant to the Court’s February 28, 2008 Order in Civil Action No, 04-940~JJF and the
March 5, 2008 Order on Joint Motion to Stay All Proceedings (DMI. 9) in this action, the Piaintiff,
The Procter & Gamble Company (°‘P&G"), submits the attached Proposed Order of Finai
Judgment. Notice of this Proposed Order has been provided to the Defendant, Teva
Pharmacetiticals USA, Inc ("Teva”),
P&G respecti”u1ly requests entry ol? the attached Proposed Order, Should the Court desire
brieting with respect to the injunctive relief requested, P&G wit} discuss an appropriate brieting
schedule with Teva and submit a proposed schedule to the Court For approval.
OF COUNSEL: IT1'GCICi'ECI< L. gottrell IE555) ;
Wiliiam F. Lee Steven J, Finerrian (4025)
David B. Bassett Richards Layton & Finger, P.A,
Vinita Ferrera PRO, Box 55i
Wilmer Cutler Pici<.ering Hale and Dorr LLP One Rodney Square
60 State Street Wiimington, Deiavvare I9899—055l
Boston, Massachusetts 02I09 (302) 65l—7700
(61 7) 52645000 CottrelE@rI‘l*.com
ITill€EDE11'1@l'ITiCOl'l’1
Dated: March I3, 2008 Attorneys For Plaintiff The Procter & Gamhie
Company
nt r rozam 1 -r

Case 1:08-cv-00066-JJF Document 10 Filed O3/13/2008 Page 2 of 2
IN THE UNITED STATES DISTRICT COURT
DISTRICT OF DELAWARE
CERTIFICATE OF SERVICE
I hereby certify that on Marcin i3, 2008, I eiectronicaliy filed the foregoing document
with the Clerk of Court using CM/ECP which will send notification of such filing(s) and Hand
Delivered to the following:
Karen L, Pascale, Esquire
Young Conaway Stargait & Taylor, LLP
The Brandywine Building
i000 West Street, i7ti1 Floor
P. O, Box 391
Wilmington, DIE i9899~O39i
I iiereby certify that on March i3, 2008, I have sent by Electronic Mail, the foregoing
docunient to the following non-registered participants:
James Galbraith
Maria Luisa Painiese
Antiiony Pfeffer
Kenyon & Kenyon
One Broadway
New York, NY l0004
Steven .l. Filjgftll
Riciiards, Layton & Finger, PA.
One Rodney Square
PO. Box 551
Wilmington, Delaware 19899
(302) 65i~7700
FilI€lIl811@1`ifiCOIH
i2tz=1-zxiisaia-1

Case 1:08-cv-00066-JJF Document 10-2 Filed O3/13/2008 Page 1 of 2
IN TI-IE UNITED STATES DISTRICT COURT
FOR `1`HE DISTRICT OI: DELAWARE

THE PROCTIER & GAMBLE COMRANY, )
Piaintiff, I
v. i Civil Action No. 08~66~J.iF
TEVA PI·IARMACIEUTICAI,.S USA, INC., g
Defendant i

[1’ROI’OSED| ORDER OF FINAL JUDGMENT
This action having been stayed pending trial in the reiated action, Civil Action No. 04~
CV·940 (JJF), which caine to triai in November 2006 before this Court, I··Ionorable Joseph J.
Iiarnan, Jr,, District Judge, presiding, and pursuant to the Joint Motion to Stay Ali Proceedings
submitted by the parties on February 26, 2008 (DI 7) and entered by the Court on March 5,
2008;
NOW THEREFORI5, IT IS ORDERED AND ADJUDGED for the reasons set forth in
the Conrt`s Opinion dated Iiebrnary 28, 2008 in Civii Action No. 0¢l~C`\/-940 (JJF), that Final
Judgment is entered in favor ol" the i’laintil`l', The Procter & Gamble Company ("P&G"), and
against the Defendant, Teva Phannaceuticals USA, Inc. ("Teva”’), on I°&G’s ciaims that Teva
has iniiinged Claims 4, I6, and 23 ot°U.S. Patent No. 5,583,122 ("ti1e ’ 122 patent");
AND IT IS FURTIIIER ORDERED AND ADJUDGED that claims 4, 16, and 23 ofthe
‘ I 22 patent are valid and enl’orceable;
AND IT IS RURTI-IER ORDERED that, pursuant to 35 USC. § .27l(e)(·’·I)(A), the
effective date of any approvai oI’Teva’s Abbreviated New Ding Application No. 79—2i5 shall be
iz.t1=i-32a2721~1

Case 1 :08-cv-00066-JJF Document 10-2 Filed O3/13/2008 Page 2 of 2
a date which is not eariier than the date of expiration of the *122 patent, including any extensions
and regulatory exclusivitics that are granted and not suczcessltally chaiiengerig
AND IT IS FURTI~II;ZR ORDERED that, pursuant to 35 USC. § 271(e)(¢l)(B), Teva and
its successors—in~interest, officers, agents, servants, employees and attorneys, and those persons
in active concert or participation with any of them who receive actuai notice of this Order by
personal service or otherwise, are hereby enjoined item commercially rnaking, using, oilering to
sell or selling within the United States, or importing into the United States any products that
iniringe the ‘122 patent, including the 75 mg risecironate sodium tablets For treatment or
prevention oi" osteoporosis that are the subject ol' Abbreviated New Drug Application No, 79—
2K5, untii the lm'er of the expiration of the ‘122 patent (December 10, 2013) or the expiration oft
any patent terrn extensions or any regulatory excinsivities that are granted and not successlirliy
chaiiengedr
DATED THIS _____ DAY OF , 2008r
United States District Judge
- 2 -

Case 1:08-cv-00066-JJF

Document 10

Filed 03/13/2008

Page 1 of 2

Case 1:08-cv-00066-JJF

Document 10

Filed 03/13/2008

Page 2 of 2

Case 1:08-cv-00066-JJF

Document 10-2

Filed 03/13/2008

Page 1 of 2

Case 1:08-cv-00066-JJF

Document 10-2

Filed 03/13/2008

Page 2 of 2